These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. J Epidemiol Community Health; 1989 Mar; 43(1):53-60. PubMed ID: 2556492 [Abstract] [Full Text] [Related]
23. Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look. Kjaer SK, de Villiers EM, Cağlayan H, Svare E, Haugaard BJ, Engholm G, Christensen RB, Møller KA, Poll P, Jensen H. Br J Cancer; 1993 Apr; 67(4):830-7. PubMed ID: 8385982 [Abstract] [Full Text] [Related]
24. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Jha PK, Beral V, Peto J, Hack S, Hermon C, Deacon J, Mant D, Chilvers C, Vessey MP, Pike MC. Lancet; 1993 May 01; 341(8853):1116-8. PubMed ID: 8097804 [Abstract] [Full Text] [Related]
25. Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer. Vass-Sørensen M, Abeler V, Berle E, Pedersen B, Davy M, Thorsby E, Norrild B. Gynecol Oncol; 1984 Jul 01; 18(3):349-58. PubMed ID: 6086470 [Abstract] [Full Text] [Related]
26. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls. Gilman SC, Docherty JJ, Clarke A, Rawls WE. Cancer Res; 1980 Dec 01; 40(12):4640-7. PubMed ID: 6254649 [Abstract] [Full Text] [Related]
27. Editorial: Herpesvirus and cancer of uterine cervix. Br Med J; 1976 Mar 20; 1(6011):671-2. PubMed ID: 175880 [Abstract] [Full Text] [Related]
29. [Epidemiological aspects of cervico-uterine cancer in the Republic of Panama]. Reeves WC, Brenes MM, de Britton RC, Quiroz E, Rawls WE, Valdés PF, de la Guardia ME, Cuevas M. Rev Med Panama; 1984 May 20; 9(2):123-35. PubMed ID: 6087422 [No Abstract] [Full Text] [Related]
32. Cervical cancer in the Republic of Panama. Reeves WC, Brenes MM, de Britton RC, Valdes PF, Joplin CF. Am J Epidemiol; 1984 May 20; 119(5):714-24. PubMed ID: 6720669 [Abstract] [Full Text] [Related]
34. Herpes simplex virus. An expanding relationship to human cancer. Smith JW. J Reprod Med; 1983 Feb 20; 28(2):116-22. PubMed ID: 6300393 [Abstract] [Full Text] [Related]
35. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2. Arsenakis M, Georgiou GM, Welsh JK, Cauchi MN, May JT. Int J Cancer; 1980 Jan 15; 25(1):67-71. PubMed ID: 6249764 [Abstract] [Full Text] [Related]
36. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes. Vestergaard BF. Dev Biol Stand; 1982 Jan 15; 52():95-8. PubMed ID: 6299863 [Abstract] [Full Text] [Related]
38. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix]. Meng XJ. Zhonghua Zhong Liu Za Zhi; 1989 Mar 15; 11(2):108-10. PubMed ID: 2553361 [Abstract] [Full Text] [Related]
40. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups. Anzai T, Dreesman GR, Courtney RJ, Adam E, Rawls WE, Benyesh-Melnick M. J Natl Cancer Inst; 1975 May 15; 54(5):1051-9. PubMed ID: 165303 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]